Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses.

This study investigates the key proteins of the equine infectious anaemia virus (EIAV) that are recognized by cytotoxic T lymphocytes (CTLs) in the horses. The researchers believe that a vaccine construct containing the p15 and p26 proteins could potentially stimulate CTLs in most horses.

Introduction to the Study

• The study aims to identify key proteins in the Equine Infectious Anaemia Virus (EIAV) that are most commonly recognized by cytotoxic T lymphocytes (CTLs) in infected horses.
• The goal of the research is to provide insights that could contribute to the development of vaccines that effectively stimulate an immune response.

Methodology

• Researchers studied seven horses that had been infected with EIAV for periods ranging from 0.5 to 7 years.
• They utilized target cells that were transduced (introduced) with the retroviral vector to express viral proteins, and used these cells in the CTL assays.
• Through this process, they examined how CTL recognized various EIAV proteins such as Gag p15, p26, SU, Pol, TM, and S2.

Results

• Results revealed that all the infected horses (100%) recognized the Gag p15 protein.
• Similarly, 86% of the infected horses recognized the p26 protein.
• However, other proteins were recognized less frequently with SU and the middle third of Pol protein recognized by 43%, TM by 29%, and S2 by 14% of infected horses.

Implications

• Based on the high recognition rate of the p15 and p26 proteins by the CTLs in the infected horses, the researchers suggest that a vaccine construct expressing these two proteins could potentially stimulate an immune response in most horses.
• This research provides valuable insights that may guide the development of more effective lentiviral vaccines for horses by targeting these key viral proteins.